Biobanks, rare tumours and the importance of collecting primary material

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

The molecular basis of cancer

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Advances in geriatric, medical oncology

Results from the SIOG task force on geriatric assessment

Assessing treatment tools and long term effects in geriatric oncology

Radium-223: A breakthrough in treatment for advanced prostate cancer?

What does NICE approval for Oncotype Dx in breast cancer mean?